Skip to main content

Post-operative Pain Management

0
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Atricure CryoSPHERE MAX ProbeN/A1 trial
Active Trials
NCT07281118Recruiting148Est. Nov 2027
AtriCure
AtriCureCA - Pleasanton
1 program
Atricure CryoSPHERE MAX ProbeN/A

Trial Timeline

Clinical trial activity over time

2025
2026
2027
Angeles TherapeuticsAtricure CryoSPHERE MAX Probe

Clinical Trials (1)

Total enrollment: 148 patients across 1 trials

NCT07281118Angeles TherapeuticsAtricure CryoSPHERE MAX Probe

Intercostal Cryoanalgesia in Double Lung Transplant Recipients

Start: Dec 2025Est. completion: Nov 2027148 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 148 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.